Economic Impact of Asthma Therapy With Fluticasone Propionate, Montelukast, or Zafirlukast in a Managed Care Population

Pharmacotherapy- United States

doi 10.1592/phco.22.3.166.33548

Full Text

Abstract

Available in

Date

February 1, 2002

Authors

Dev S. Pathak

E. Anne Davis

Richard H. Stanford

Publisher

Wiley-Blackwell

Related search

Comparative Efficacy and Safety of Low-Dose Fluticasone Propionate and Montelukast in Children With Persistent Asthma

English

P111 Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Superior to Fluticasone Propionate Alone in Improving Asthma Control

English

Improvement in Asthma Endpoints When Aiming for Total Control: Salmeterol/Fluticasone Propionate Versus Fluticasone Propionate Alone

Primary Care Respiratory Journal

2007

English

Efficacy of Treatment With Montelukast, Fluticasone Propionate and Budesonide Liquid Suspension for the Prevention of Recurrent Asthma Paroxysms in Children With Wheezing Disorders

Experimental and Therapeutic Medicine

English

Austri, a Large Randomized Study in Adolescents and Adults With Asthma, Assessing the Safety and Efficacy of Salmeterol in Combination With Fluticasone Propionate Compared to Fluticasone Propionate Alone

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2016

English

Cost-Effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients

Yakugaku Zasshi

Pharmacology

Pharmaceutical Science

2010

English

P112 Fluticasone Propionate/Formoterol Fumarate Combination Therapy Reduces the Risk of Exacerbations Compared With Its Individual Components in Patients With Asthma

English

Comparison of Fluticasone Propionate With Budesonide Administered via Nebulizer: A Randomized Controlled Trial in Patients With Severe Persistent Asthma

Journal of Thoracic Disease

Pulmonary

Respiratory Medicine

2017

English

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma

Pulmonary Pharmacology and Therapeutics

English

Amanote Research

Economic Impact of Asthma Therapy With Fluticasone Propionate, Montelukast, or Zafirlukast in a Managed Care Population

Pharmacotherapy- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Comparative Efficacy and Safety of Low-Dose Fluticasone Propionate and Montelukast in Children With Persistent Asthma

P111 Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Superior to Fluticasone Propionate Alone in Improving Asthma Control

Improvement in Asthma Endpoints When Aiming for Total Control: Salmeterol/Fluticasone Propionate Versus Fluticasone Propionate Alone

Efficacy of Treatment With Montelukast, Fluticasone Propionate and Budesonide Liquid Suspension for the Prevention of Recurrent Asthma Paroxysms in Children With Wheezing Disorders

Austri, a Large Randomized Study in Adolescents and Adults With Asthma, Assessing the Safety and Efficacy of Salmeterol in Combination With Fluticasone Propionate Compared to Fluticasone Propionate Alone

Cost-Effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients

P112 Fluticasone Propionate/Formoterol Fumarate Combination Therapy Reduces the Risk of Exacerbations Compared With Its Individual Components in Patients With Asthma

Comparison of Fluticasone Propionate With Budesonide Administered via Nebulizer: A Randomized Controlled Trial in Patients With Severe Persistent Asthma

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma